Virus Inactivation in the 1990s and into the 21st Century: Part 4, Culture Media, Biotechnology Products, and Vaccines

Sofer,Gail;

Publication

Article

January 15, 2003

BioPharm International

BioPharm International-01-01-2003

Volume16

Issue 1

Virus Inactivation in the 1990s and into the 21st Century: Part 4, Culture Media, Biotechnology Products, and Vaccines

Author(s):

Gail Sofer

by Gail Sofer, BioReliance With West Nile virus in the news, viral inactivation is under public scrutiny. Yet, the culture media, the therapeutic product, and the potential viral contaminants can all affect the inactivation method chosen during production. Viral inactivation techniques ? those tried or used in manufacturing or in final biopharmaceuticals, vaccines, and media products ? have been gathered from recent scientific literature and organized in this article series as an addition to your process development toolbox.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Virus Inactivation in the 1990s and into the 21st Century: Part 4, Culture Media, Biotechnology Products, and Vaccines

Biotech World: Canada's Supreme Court says "No" to Harvard Mouse

Rethinking the Economics of Chromatography: New Technologies and Hidden Costs

Outsourcing Outlook: Using Virtual Private Networks to Gain Competitive Advantage

Inside Washington: Coverage and Consolidation ? Key Issues for Biotech Companies

Employing Near-Infrared Spectroscopic Methods of Analysis for Fermentation Monitoring and Control: Part 2, Implementation Strategies

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!